MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • Potential Changes to MS Treatment Access in Australia
  • MS Auckland Webinar: AHSCT as a Treatment for MS
  • MS Auckland Webinar: Remyelination Research in MS
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Tagged Treatments

Ocrevus

Ocrevus and PPMS: Where to from here?

MStranslate
September 10, 2018
Ocrelizumab, Opinion, Treatments
The following is an opinion piece written by MStranslate co-founder, Brett Drummond. Let’s rewind to last March last year…there is worldwide...
cannabis for chronic pain

Cannabis and Chronic Pain: Research Summary

MStranslate
July 19, 2018
Medicinal Cannabis, Research, Treatments
Research Summary: Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort...
Dr Travis Stiles

Developing Next Gen Multiple Sclerosis Therapies: Part 5

MStranslate
April 26, 2018
Dr Travis Stiles, Research, Treatments, Understanding Science
5 Comments
The following is part of a MStranslate exclusive series which highlights the struggles and obstacles in developing the next generation of therapies...
Dr Travis Stiles

Developing Next Gen Multiple Sclerosis Therapies: Part 4

MStranslate
April 10, 2018
Dr Travis Stiles, Research, Treatments, Understanding Science
The following is part of a MStranslate exclusive series which highlights the struggles and obstacles in developing the next generation of therapies...
Dr Travis Stiles

Developing Next Gen Multiple Sclerosis Therapies: Part 3

MStranslate
March 27, 2018
Dr Travis Stiles, Research, Treatments, Understanding Science
1 Comment
The following is part of a MStranslate exclusive series which highlights the struggles and obstacles in developing the next generation of therapies...
Dr Travis Stiles

Developing Next Gen Multiple Sclerosis Therapies: Part 2

MStranslate
March 20, 2018
Dr Travis Stiles, Research, Treatments, Understanding Science
The following is part two of an MStranslate exclusive series which highlights the struggles and obstacles in developing the next generation of...
Dr Travis Stiles

Developing Next Gen Multiple Sclerosis Therapies: Part 1

MStranslate
March 13, 2018
Dr Travis Stiles, Research, Treatments, Understanding Science
1 Comment
The following is part of an MStranslate exclusive series which highlights the struggles and obstacles in developing the next generation of therapies...
multiple sclerosis

Support the Future of Multiple Sclerosis Research

MStranslate
February 28, 2018
Community, Research, Treatments
...
sunscreen

Could Sunscreen be a Treatment for MS?

MStranslate
September 13, 2017
Research, Treatments
Recently, you may have heard about a study that has revealed that sunscreen (or more accurately certain compounds in sunscreen) can prevent the...
lifestyle treatments

Do We Need Clinical Trials for MS Lifestyle Treatments?

MStranslate
August 30, 2017
Lifestyle, Opinion, Treatments
1 Comment
We have been discussing lifestyle factors, such as diet and exercise, a lot recently on MStranslate.  This has been presented both in terms of the...
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Recent Posts

  • Potential Changes to MS Treatment Access in Australia
  • MS Auckland Webinar: AHSCT as a Treatment for MS
  • MS Auckland Webinar: Remyelination Research in MS
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026

Recent Comments

  • MStranslate on Multiple Sclerosis Research In 2026
  • MStranslate on Multiple Sclerosis Research In 2026
  • K on Multiple Sclerosis Research In 2026
  • Mohammad on Multiple Sclerosis Research In 2026
  • FDA Decision On Tolebrutinib - MStranslate on Multiple Sclerosis in 2025 – Key Developments to Date

Calendar

August 2026
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
« Jul    

Archives

Categories

Posts

  • Potential Changes to MS Treatment Access in Australia
  • MS Auckland Webinar: AHSCT as a Treatment for MS
  • MS Auckland Webinar: Remyelination Research in MS
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.